<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Reprod Biomed (Yazd)</journal-id><journal-id journal-id-type="iso-abbrev">Int J Reprod Biomed (Yazd)</journal-id><journal-id journal-id-type="publisher-id">IJRB</journal-id><journal-title-group><journal-title>International Journal of Reproductive Biomedicine</journal-title></journal-title-group><issn pub-type="ppub">2476-4108</issn><issn pub-type="epub">2476-3772</issn><publisher><publisher-name>Research and Clinical Center for Infertility</publisher-name><publisher-loc>Yazd, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28462399</article-id><article-id pub-id-type="pmc">5405220</article-id><article-id pub-id-type="publisher-id">ijrm-15-083</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Aleyasin</surname><given-names>Ashraf</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Aghahosseini</surname><given-names>Marzieh</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Safdarian</surname><given-names>Leili</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Noorzadeh</surname><given-names>Maryam</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fallahi</surname><given-names>Parvin</given-names></name><degrees>M.L.D.</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rezaeian</surname><given-names>Zahra</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hoseinimosa</surname><given-names>Sedighe</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label><italic>Department of Obstetrics and Gynecology, Infertility Unit, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</italic></aff><aff id="aff2"><label>2</label><italic>Fertility and Infertility Center, Shariati Hospital, Tehran, Iran </italic></aff><author-notes><corresp id="cor">Corresponding Author: Sedighe Hoseinimosa, Department of Obstetrics and Gynecology, Fertility and Infertility Center, Shariati Hospital, North Karegar Street, Tehran, Iran. Postal Cod: 1411713135. Tel: (+98) 9128186934, Email: hoseinimosa@razi.tums.ac.ir; sedighehoseinimosa@gmail.com </corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2017</year></pub-date><volume>15</volume><issue>2</issue><fpage>83</fpage><lpage>86</lpage><history><date date-type="received"><day>1</day><month>10</month><year>2016</year></date><date date-type="rev-recd"><day>7</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>26</day><month>1</month><year>2017</year></date></history><permissions><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>There are different methods in endometrial preparation for frozen-thawed embryo transfer (FET).</p></sec><sec><title>Objective:</title><p>The purpose of this study was to compare the live birth rate in the artificial FET protocol (estradiol/ progesterone with GnRH-agonist) with stimulated cycle FET protocol (letrozole plus HMG).</p></sec><sec><title>Materials and Methods:</title><p>This randomized clinical trial included 100 women (18-42 years) randomly assigned to two groups based on Bernoulli distribution. Group I received GnRH agonist [Bucerelin, 500&#x003bc;g subcutaneously] from the previous midlutea lcycle, Then estradiol valerat [2 mg/ daily orally] was started on the second day and was increased until the observation of 8mm endometrial thickness. Finally progesterone [Cyclogest, 800 mg, vaginally] was started. Group II received letrozole on the second day of the cycle for five days, then HMG 75 IU was injected on the7<sup>th</sup> day. After observing [18 mm folliclhCG10000 IU was injected for ovulation induction. Trans cervical embryo transfer was performed in two groups. The main outcome was the live birth rate. The rate of live birth, implantation, chemical, and clinical pregnancy, abortion, cancellation and endometrial thickness were compared between two groups.</p></sec><sec><title>Results:</title><p>Implantation rate was significantly higher in group I. Live birth rate was slightly increased in group I without significant difference (30% vs. 26%). The rate of chemical and clinical pregnancy was similar in two groups. The abortion rate was lower in letrozole protocol but the difference was not statistically significant. The mean endometrial thickness was not different between two groups. </p></sec><sec><title>Conclusion:</title><p>Letrozole plus HMG method cannot improve pregnancy outcomes in frozen-thawed embryo transfer but it has only one injection compare to daily injections in artificial method.</p></sec></abstract><kwd-group><title>Key Words</title><kwd>Frozen-thawed embryo transfer</kwd><kwd>Endometrial preparation</kwd><kwd>Freeze embryo</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Frozen thawed embryo transfer (FET) has become a successful technique of Invitro Fertilization (IVF). Nevertheless, FET is a less invasive procedure for patients, reduces cost and time period, increases the cumulative pregnancy rate, and reduces multiple pregnancies (<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B5" ref-type="bibr">5</xref>). An important factor in this process is synchronization between the embryo and the endometrial development (<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B9" ref-type="bibr">9</xref>). There are different cycle regimens for endometrial preparation: natural cycle (NC-FET), modified natural cycle, stimulated cycle FET, and artificial cycle FET (AC-FET). NC-FET is a simple method, but the variation in timing of ovulation between cycles is its disadvantage. In NC-FET follicle monitoring should be done with several ultrasounds and is expensive. Modified natural cycle is an alternative method in which ovulation induced by drugs such as letrozole, clomiphene citrate or Human Menopausal Gonadotropin (HMG). In AC-FET the endometrium is prepared by estradiol and progesterone hormones with or without GnRH-agonist. There are different studies for comparison of these protocols (<xref rid="B10" ref-type="bibr">10</xref>-<xref rid="B13" ref-type="bibr">13</xref>).</p><p>The purpose of this study was to compare the pregnancy outcomes in AC-FET with the stimulated-FET prtocol for endometrial preparation in frozen thawed embryo transfer.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>This randomized controlled trial was performed at Shariati Hospital of Tehran University of Medical Sciences, Tehran Iran between February 2014 and February 2016. Inclusion criteria were all women (18-42 yr old) who were undergone endometrial preparation for first frozen embryo transfer. Infertile couples with male infertility undergone testicular sperm extraction (TESE) or percutaneous epididimal sperm aspiration (PESA); severe endometriosis (stage 3 or 4); uterine myoma&#x02265;4 cm, and fresh embryo transfer were excluded. The samples (N=100) were divided into two groups randomly based on Bernoulli distribution.</p><p>GroupI(AC-FET group, received GnRH-a (Bucerelin, Aventis, Germany) 500&#x003bc;g subcutaneously from the previous midluteal cycle (21<sup>st</sup> day). Then estradiol valerate (Daroopakhsh, Iran, 2 mg/ daily orally) was started on the second day and was increased until the observation of 8mm endometrial thickness in transvaginal ultrasound. For visualizing endometrial thickness, transvaginal ultrasound (Sonoline G20; Siemens Medical Solutions, California, USA) was performed every 4 days. After the observation of at least 8 mm endometrial thickness, progesterone (Cyclogest, Germany, 800 mg) was started vaginally. After 3 days, about three good quality embryos (blastocyst stage) were transferred on day 16-19 by catheter (COOK MEDICAL Embryo Transfer).</p><p>GroupII, (stimulated-FET group, received letrozole (Iran hormone, Iran, 5 mg/daily) orally on the second day of the cycle for five days. Then HMG (Ferring, Germany, 75IU daily) was injected on the7<sup>th</sup> day. After the observation of 18mm follicle in trans vaginal ultrasound, human chorionic gonadotropin (hCG) (Ferring, Germany, 10000IU, and IM) was injected for ovulation induction. About three good quality embryos (blastocyst stage) were transferred on day 16-19 by catheter (Cook Medical Embryo Transfer). The policy to transfer up to 3 embryos in patients was adopted in two groups. The rate of live birth, implantation, chemical, and clinical pregnancy, abortion, and cancellation were compared between two groups. Chemical pregnancy was through serum &#x003b2;hCG analysis 16 days after frozen embryo transfer. Clinical pregnancy was detected by pregnancy sac observation in trans vaginal ultrasound two weeks after positive pregnancy test.</p><p>
<bold>Ethical consideration</bold>
</p><p>This study was approved by Ethics Committee of Tehran University of Medical Sciences [Ref. number: 90-04-30-15625-52546]. All participants signed an informed consent for participation in this study.</p><p>
<bold>Statistical analysis</bold>
</p><p>All data were analyzed by SPSS software (SPSS, version 21 for windows SPSS Inc., Chicago. IL). Statistical tests were Student's <italic>t</italic>-test and Chi-square test. P&#x0003c;0.05 was significant.</p></sec><sec sec-type="results"><title>Results</title><p>One hundred women undergone first FET were enrolled in two our study groups (n=50/each). There were no significant differences in age, duration of infertility, and number of transferred embryos between two groups (<xref ref-type="table" rid="T1">Table I</xref>). Pregnancy outcomes in both groups are shown in <xref ref-type="table" rid="T2">table II.</xref> There were 18 chemical pregnancies in each group. In group I, from 18 pregnancies, 8 pregnancies were aborted. There were 10 deliveries (20.0%) in group I (3 twins and 1 triplet). In group II, from 18 pregnancies, 6 pregnancies were aborted. There were 12 deliveries (24.0%) in group II (one twin). We had 15 live births (30%) in group &#x00406; and 13 (26%) in group II.</p><table-wrap id="T1" position="float"><label>Table &#x00406;</label><caption><p>Comparison of demographic characteristics in two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Characteristics</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Group</bold>
<bold> &#x00406;</bold>
<bold> (AC-FET group)</bold>
<break/>
<bold>(n=50)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Group </bold>
<bold>&#x0041f;</bold>
<bold> (stimulated-FET group)</bold>
<break/>
<bold>(n=50)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>p-value</bold>
<xref ref-type="table-fn" rid="TFN2">**</xref>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age(years)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">30.10&#x000b1;4.34</td><td align="center" valign="middle" rowspan="1" colspan="1">30.54&#x000b1;4.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.60</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Infertility duration (years)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">6.24&#x000b1;<italic>3.58</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">7.04&#x000b1;3.47</td><td align="center" valign="middle" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Number of transferred embryos<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">3.16&#x000b1;0.51</td><td align="center" valign="middle" rowspan="1" colspan="1">3.19&#x000b1;3.19</td><td align="center" valign="middle" rowspan="1" colspan="1">0.80</td></tr></tbody></table><table-wrap-foot><p>AC-FET: artificial frozen embryo transfer</p><fn id="TFN1"><label>*</label><p> Mean&#x000b1;SD </p></fn><fn id="TFN2"><label>**</label><p>Independent Student's<italic>t</italic>-test was used</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table &#x0041f;</label><caption><p>Comparative analysis of pregnancy outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Characteristic</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Group </bold>
<bold>&#x00406;</bold>
<bold> (AC-FET group)</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Group </bold>
<bold>&#x0041f;</bold>
<bold> (stimulated-FET group)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>p-value</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Endometrial thickness(mm)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">8.06&#x000b1;0.31</td><td align="center" valign="middle" rowspan="1" colspan="1">8.08&#x000b1;0.40</td><td align="center" valign="middle" rowspan="1" colspan="1">0.750</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Chemical pregnancy rate</td><td align="center" valign="middle" rowspan="1" colspan="1">18.50 (36%)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.50 (36%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.582</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Clinical pregnancy rate</td><td align="center" valign="middle" rowspan="1" colspan="1">13.50 (26%)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.50 (28%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Delivery rate</td><td align="center" valign="middle" rowspan="1" colspan="1">10.50 (20%)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.50 (24%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.454</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Live birth rate</td><td align="center" valign="middle" rowspan="1" colspan="1">15.50 (30%)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.50 (26%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.405</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Implantation rate</td><td align="center" valign="middle" rowspan="1" colspan="1">11.39%</td><td align="center" valign="middle" rowspan="1" colspan="1">9.8%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.029</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Abortion rate</td><td align="center" valign="middle" rowspan="1" colspan="1">8.50 (16%)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.50 (12%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.734</td></tr></tbody></table><table-wrap-foot><p>Independent Student&#x02019;s <italic>t</italic>-test was used </p><p>Because of having twins live birth is more that clinical pregnancy outcomes. </p><fn id="TFN3"><label>*</label><p>Mean&#x000b1;SD</p></fn></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Consort flow chart</p></caption><graphic xlink:href="ijrb-15-083-g001"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>In this study, we detected that live birth rate was slightly increased in artificial protocol without significant difference. Although implantation rate was significantly higher in the artificial cycle, chemical pregnancy rate was equal in two groups (36%). In letrozole protocol, the rate of clinical pregnancy was slightly increased and the abortion rate was lower. In this group the delivery rate was higher than artificial protocol (24% vs. 20%) but was not statistically significant. Multiple pregnancies were higher in artificial group than letrozole group, then live birth rate was slightly increased in this group.</p><p>In a recent study carried out by Sibai <italic>et al</italic> (2016) in which 94 cycles of letrozole were compared with 96 cycles of hormonal preparation the ongoing pregnancy rate was significantly higher in the letrozole group (47.9% v 32.3%) (p=0.02) but the chemical pregnancy rate was not significantly higher (53.2% v 40.6%) (<xref rid="B14" ref-type="bibr">14</xref>). Song-jun Li <italic>et al</italic> reported that the embryo implantation rate, clinical pregnancy rate, and live birth rate of patients in letrozole group was significantly higher than the HRT group (30.4&#x000a0;% vs. 22.8%), (53.2% vs. 44.4%), and (44.6&#x000a0;% vs. 32.5&#x000a0;% respectively) (<xref rid="B15" ref-type="bibr">15</xref>). In Huang study, in 689 letrozole FET cycles, the live birth rate was 38.89% and the clinical pregnancy rate was 47% (<xref rid="B16" ref-type="bibr">16</xref>).</p><p>We found that spontaneous abortion rate was not significantly lower in the letrozole group (12% vs, 16%). This is in agreement with the observation of Sibai <italic>et al </italic>(5.3% v 8.3%)while in Li study this rate was significantly lower than the HRT group (12.0% vs 21.0%) (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). The mean endometrial thickness before transfer did not vary between two groups. In Sibai and colleagues study the mean endometrial thickness in the letrozole group was significantly lower (9.9 mm vs. 9.1 mm) (<xref rid="B14" ref-type="bibr">14</xref>). </p><p>In a study carried out by Jouan<italic>et et al </italic>the pregnancy rate per transfer in clomiphene citrate group was higher than AC-FET group (24.3 vs. 20.8) while miscarriage rate was lower (23.2 vs. 29.8) (<xref rid="B17" ref-type="bibr">17</xref>). There are several studies about endometrial preparation protocols in FET. Konc<italic> et al</italic> (2010) in a retrospective study compared three cycle regimens: natural, stimulated (HMG/rFSH) and artificial. The pregnancy rate in the natural cycle was 34.9%, in the stimulated cycle was 27.6% and in the artificial cycle was 24.7%. They detected that all three procedures were equally effective in pregnancy outcomes. Our results were similar to Konc <italic>et al </italic>(<xref rid="B18" ref-type="bibr">18</xref>). </p><p>In a different study artificial cycle was compared with stimulated cycle which was induced by HMG for endometrial preparation prior to FET(<xref rid="B19" ref-type="bibr">19</xref>). There was no difference in clinical pregnancy rate (41.0&#x02009;% vs. 41.6&#x000a0;%), ongoing pregnancy rate (36.6&#x02009;% vs. 34.7&#x000a0;%) and live birth rate (30.0&#x02009;% vs. 31.7&#x000a0;%) between two groups simillar to our study (<xref rid="B19" ref-type="bibr">19</xref>). Cochrane meta-analysis (2008) reported that there was no preference for methods to another (<xref rid="B10" ref-type="bibr">10</xref>). In a randomized multicenter clinical trial, Groenewoud<italic> et al</italic> in 2012 detected that there is no significant difference in live birth rates between natural and artificial methods (<xref rid="B11" ref-type="bibr">11</xref>). In another study in 2016, modified natural withthe artificial cycle for cryo-thawed embryo transferwere compared and it was observed observed that there is no significant differences in live birth rate (11.5% vs. 8.8%) and clinical pregnancy rate (19% vs. 16.0%) between two groups of modified NC-FET and AC-FET(<xref rid="B12" ref-type="bibr">12</xref>). A recent meta-analysis by Yarali<italic> et al</italic> shows that at the moment there is not sufficient evidence to support the use of any protocols (<xref rid="B13" ref-type="bibr">13</xref>).</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In the present study we found that there was no significant difference between letrozole protocol and artificial protocol for endometrial preparation in FET. Letrozole method has only one injection but in artificial method, daily injections should be done. </p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the Vice-Chancellery of Tehran University of Medical Sciences for supporting our study and Dr. Reza Poormahmoodian for his assistance. </p></ack><sec><title>Note</title><p>
<bold><italic>Registration ID in IRCT: </italic></bold>
<bold><italic>IRCT201306256689N3</italic></bold>
</p></sec><sec sec-type="COI-statement"><title>Conflict of interest</title><p>There is no conflict of interest in this article.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aflatoonian</surname><given-names>A</given-names></name><name><surname>Mansoori</surname><given-names>MF</given-names></name><name><surname>Mashayekhy</surname><given-names>M</given-names></name><name><surname>Mohamadian</surname><given-names>F</given-names></name></person-group><article-title>Comparison of early pregnancy and neonatal outcomes after frozen and fresh embryo transfer in ART cycles</article-title><source> J Assist Reprod Genet</source><year>2010</year><volume>27</volume><fpage>695</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">20886367</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>HZ</given-names></name><name><surname>Qiao</surname><given-names>J</given-names></name><name><surname>Chi</surname><given-names>HB</given-names></name><name><surname>Chen</surname><given-names>XN</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>CH</given-names></name></person-group><article-title>Comparison of the major malformation rate of children conceived from cryopreserved embryos and fresh embryos</article-title><source> Chin Med J (Engl)</source><year>2010</year><volume>123</volume><fpage>1893</fpage><lpage>1897</lpage><pub-id pub-id-type="pmid">20819574</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belva</surname><given-names>F</given-names></name><name><surname>Henriet</surname><given-names>S</given-names></name><name><surname>Van</surname><given-names>den Abbeel E</given-names></name><name><surname>Camus</surname><given-names>M</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>Van</surname><given-names>der Elst J</given-names></name><etal/></person-group><article-title>Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles</article-title><source> Hum Reprod</source><year>2008</year><volume>23</volume><fpage>2227</fpage><lpage>2238</lpage><pub-id pub-id-type="pmid">18628260</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basirat</surname><given-names>Z</given-names></name><name><surname>Adib</surname><given-names>Rad H</given-names></name><name><surname>Esmailzadeh</surname><given-names>S</given-names></name><name><surname>Jorsaraei</surname><given-names>SGhA</given-names></name><name><surname>Hajian-Tilaki</surname><given-names>K</given-names></name><name><surname>Pasha</surname><given-names>H</given-names></name><etal/></person-group><article-title>Comparison of pregnancy rate between fresh embryo transfers and frozen-thawed embryo transfers following ICSI treatment</article-title><source> Int J Reprod BioMed</source><year>2016</year><volume>14</volume><fpage>39</fpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aflatoonian</surname><given-names>A</given-names></name><name><surname>Karimzadeh</surname><given-names>Maybodi MA</given-names></name><name><surname>Aflatoonian</surname><given-names>N</given-names></name><name><surname>Tabibnejad</surname><given-names>N</given-names></name><name><surname>Amir-Arjmand</surname><given-names>MH</given-names></name><name><surname>Soleimani</surname><given-names>M</given-names></name><etal/></person-group><article-title>Perinatal outcome in fresh versus frozen embryo transfer in ART cycles</article-title><source> Int J Reprod BioMed</source><year>2016</year><volume>14</volume><fpage>167</fpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aflatoonian</surname><given-names>A</given-names></name><name><surname>Asgharnia</surname><given-names>M</given-names></name></person-group><article-title>Factors affecting the successful embryo transfer</article-title><source> Iran J Reprod Med</source><year>2006</year><volume>4</volume><fpage>45</fpage><lpage>50</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikzad</surname><given-names>H</given-names></name><name><surname>Kabir-Salmani</surname><given-names>M</given-names></name><name><surname>Shiokawa</surname><given-names>Sh</given-names></name><name><surname>Akimoto</surname><given-names>Y</given-names></name><name><surname>Iwashita</surname><given-names>M</given-names></name></person-group><article-title>Co-expression of galectin-3 and? v? 3 integrin at pinopodes of human endometrium</article-title><source> Iran J Reprod Med</source><year>2010</year><volume>8</volume><fpage>145</fpage><lpage>152</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wirleitner</surname><given-names>B</given-names></name><name><surname>Schuff</surname><given-names>M</given-names></name><name><surname>Stecher</surname><given-names>A</given-names></name><name><surname>Murtinger</surname><given-names>M</given-names></name><name><surname>Vanderzwalmen</surname><given-names>P</given-names></name></person-group><article-title>Pregnancy and birth outcomes following fresh or vitrified embryo transfer according to blastocyst morphology and expansion stage, and culturing strategy for delayed development</article-title><source> Hum Reprod</source><year>2016</year><fpage>dew127</fpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomaaa</surname><given-names>H</given-names></name><name><surname>Robert</surname><given-names>F</given-names></name></person-group><article-title>Caspera, Navid Esfandiaria, Yaakov Bentova Non-synchronized endometrium and its correction in non-ovulatory cryopreserved embryo transfer cycles</article-title><source> Reprod Biomed Online</source><year>2015</year><volume>30</volume><fpage>378</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">25676169</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghobara</surname><given-names>T</given-names></name><name><surname>Vandekerckhove</surname><given-names/></name></person-group><article-title>Cycle regimens for frozen-thawed embryo transfer</article-title><source> Cochrane Database</source><year>2008</year><volume>1</volume><fpage>CD003414</fpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groenewoud</surname><given-names>ER</given-names></name><name><surname>Cantineau</surname><given-names>AEP</given-names></name><name><surname>Kollen</surname><given-names>BJ</given-names></name><name><surname>Macklon</surname><given-names>NS</given-names></name><name><surname>Cohlen</surname><given-names>BJ</given-names></name></person-group><article-title>What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis</article-title><source> Hum Reprod Update</source><year>2013</year><volume>19</volume><fpage>458</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">23820515</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groenewoud</surname><given-names>ER</given-names></name><name><surname>Kollen</surname><given-names>BJ</given-names></name><name><surname>Oraiby</surname><given-names>A Al</given-names></name><name><surname>Brinkhuis</surname><given-names>EA</given-names></name></person-group><article-title>A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer</article-title><source> Hum Reprod</source><year>2016</year><volume>31</volume><fpage>1483</fpage><lpage>1492</lpage><pub-id pub-id-type="pmid">27179265</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarali</surname><given-names>H</given-names></name><name><surname>Polat</surname><given-names>M</given-names></name><name><surname>Mumusoglu</surname><given-names>S</given-names></name><name><surname>Yarali</surname><given-names>I</given-names></name><name><surname>Bozdag</surname><given-names>G</given-names></name></person-group><article-title>Preparation of endometrium for frozen embryo replacement cycles: a systematic review and meta-analysis</article-title><source> J Assist Reprod Genet</source><volume>2016</volume><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoda</surname><given-names>S</given-names></name><name><surname>El</surname><given-names>Husseiny A</given-names></name><name><surname>Elgindy</surname><given-names>E</given-names></name></person-group><article-title>Letrozole versus artificial hormonal endometrial preparation for vitrified&#x02013;warmed embryos transfer cycles</article-title><source> Middle East Fertil Soc J</source><year>2016</year><volume>21</volume><fpage>96</fpage><lpage>100</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>SJ</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Chai</surname><given-names>XSh</given-names></name><name><surname>Zhou</surname><given-names>YY</given-names></name><name><surname>Chen</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Letrozole ovulation induction: an effective option in endometrial preparation for frozen-thawed embryo transfer</article-title><source> Arch Gynecol Obstet</source><year>2014</year><volume>289</volume><fpage>687</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">24121690</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>PX</given-names></name><name><surname>Wei</surname><given-names>JH</given-names></name><name><surname>Wei</surname><given-names>LH</given-names></name></person-group><article-title>Gonadotropin-releasing hormone agonist for oocyte triggering in endometrial preparation of letrozole stimulation protocols does not affect clinical outcome of frozen-thawed embryo transfer</article-title><source> Int J Clin Exp Med</source><year>2015</year><volume>8</volume><fpage>19072</fpage><pub-id pub-id-type="pmid">26770535</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jouan</surname><given-names>C</given-names></name><name><surname>Emonard</surname><given-names>V</given-names></name><name><surname>Ruggeri</surname><given-names>P</given-names></name><name><surname>Debelle</surname><given-names>L</given-names></name><name><surname>Hincourt</surname><given-names>N</given-names></name><name><surname>Lorquet</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pregnancy outcome following frozen embryo transfer after artificial cycle or treatment by clomiphene citrate</article-title><source> Gynecol Endocrinol</source><volume>2016</volume><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konc</surname><given-names>J</given-names></name><name><surname>Kanyo</surname><given-names>K</given-names></name><name><surname>Varga</surname><given-names>E</given-names></name><name><surname>Kriston</surname><given-names>R</given-names></name><name><surname>Cseh</surname><given-names>S</given-names></name></person-group><article-title>The effect of cycle regimen used for endometrium preparation on the outcome of day 3 frozen embryo transfer cycle</article-title><source> Fertil Steril</source><year>2010</year><volume>94</volume><fpage>767</fpage><lpage>768</lpage><pub-id pub-id-type="pmid">19917505</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Endometrial preparation protocol of the frozen-thawed embryo transfer in patients with polycystic ovary syndrome</article-title><source> Arch Gynecol Obstet</source><year>2015</year><volume>291</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">25091221</pub-id></element-citation></ref></ref-list></back></article>